Evidence map›Paper›PMID 28635081›Full record

ArticleBritish journal of pharmacology2018

Understanding and improving photo-control of ion channels in nociceptors with azobenzene photo-switches.

Alexandre Mourot, Christian Herold, Michael A Kienzler, Richard H Kramer

Open access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Alexandre MourotSorbonne Universités, UPMC Univ Paris 06, Inserm, CNRS, Neuroscience Paris Seine - Institut de Biologie Paris Seine (NPS-IBPS), Paris, France.ORCID 0000-0002-8839-7481
Christian HeroldDepartment of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA, USA.
Michael A KienzlerDepartment of Chemistry, University of Maine, Orono, ME, USA.
Richard H KramerDepartment of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA, USA.
University of California, Berkeley · USCentre National de la Recherche Scientifique · FRUniversity of Maine · US

Funding

UC Berkeley Vision Science COREP30EY003176 · NEI · UNIVERSITY OF CALIFORNIA BERKELEY · PI RICHARD H KRAMER · 1985 to 2026
$16.4M
Optical Control of Synaptic Transmission for in Vivo Analysis of Brain Circuits and BehaviorU01NS090527 · NINDS · UNIVERSITY OF CALIFORNIA BERKELEY · PI ISACOFF, EHUD, KRAMER, RICHARD H · 2014 to 2016
$2.4M
Probing GABAa receptor function and plasticity with lightR01NS100911 · NINDS · UNIVERSITY OF CALIFORNIA BERKELEY · PI KRAMER, RICHARD H · 2017 to 2020
$1.8M
Howard Hughes Medical InstituteNEI NIH HHS P30 EY003176NINDS NIH HHS R01 NS100911NINDS NIH HHS U01 NS090527
6 · The paper itself

Abstract

background and purposeThe photo-isomerizable local anaesthetic, quaternary ammonium-azobenzene-quaternary ammonium (QAQ), provides rapid, optical control over pain signalling without involving genetic modification. In darkness or in green light, trans-QAQ blocks voltage-gated K EXPERIMENTAL APPROACH: Electrophysiology and molecular modelling were used to characterize the binding of cis and trans QAQ to voltage-gated K KEY

resultstrans QAQ was sixfold more potent than cis QAQ, in blocking current through Shaker K CONCLUSIONS AND IMPLICATIONS: Light-switchable local anaesthetics provide a means to non-invasively photo-control pain signalling with high selectivity and fast kinetics. Understanding the mode of action of QAQ and related compounds will help to design of drugs with improved photo-pharmacological properties. LINKED ARTICLES: This article is part of a themed section on Recent Advances in Targeting Ion Channels to Treat Chronic Pain. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.12/issuetoc.

Indexed as

LightAnimalsAzo CompoundsMaleMiceMice, Inbred C57BLModels, MolecularNociceptorsPhotochemical ProcessesPotassium Channel BlockersPotassium ChannelsQuaternary Ammonium CompoundsazobenzeneAzo CompoundsPotassium Channel BlockersPotassium ChannelsQuaternary Ammonium Compounds

Identifiers

PMID28635081
PMCPMC5980612
OpenAlexW2707957647

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.